Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zynex Inc (ZYXI)

Zynex Inc (ZYXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zynex Inc 9655 MAROON CIRCLE ENGLEWOOD CO 80112 USA

www.zynex.com Employees: 1,100 P: 800-495-6670 F: 855-845-5941

Description:

Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 266,233
Enterprise Value, $K 221,653
Shares Outstanding, K 31,846
Annual Sales, $ 184,320 K
Annual Net Income, $ 9,730 K
Last Quarter Sales, $ 49,970 K
Last Quarter Net Income, $ 2,380 K
EBIT, $ 8,850 K
EBITDA, $ 13,070 K
60-Month Beta 0.53
% of Insider Shareholders 52.13%
% of Institutional Shareholders 29.68%
Float, K 15,245
% Float 47.87%
Short Volume Ratio 0.64

Growth:

1-Year Return -0.86%
3-Year Return -37.01%
5-Year Return -0.69%
5-Year Revenue Growth 477.44%
5-Year Earnings Growth 8.00%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 0.07 on 10/24/24
Next Earnings Date 11/10/16
Earnings Per Share ttm 0.15
EPS Growth vs. Prev Qtr 75.00%
EPS Growth vs. Prev Year -30.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.150 on 06/17/14
Dividend Payable Date 06/27/14
Dividend Payout Ratio 0.00%
Most Recent Split 11-10 on 01/05/22

ZYXI Ratios

Ratio
Price/Earnings ttm 53.33
Price/Earnings forward 39.02
Price/Earnings to Growth N/A
Return-on-Equity % 13.05%
Return-on-Assets % 3.78%
Profit Margin % 5.28%
Debt/Equity 0.00
Price/Sales 1.38
Price/Cash Flow 19.44
Price/Book 7.12
Book Value/Share 1.12
Interest Coverage 12.54

ZYXI Dividends

Date Value
06/17/14 $0.1500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar